Assenagon Asset Management S.A. Puma Biotechnology, Inc. Transaction History

Assenagon Asset Management S.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$2.92 - $5.83 $204,575 - $408,449	70,060 Added 99.88%	140,205 $457,000
Q1 2024 Apr 24, 2024	SELL	$4.29 - $7.4 $63,895 - $110,215	-14,894 Reduced 17.51%	70,145 $371,000
Q4 2023 Jan 17, 2024	BUY	$2.23 - $4.49 $35,450 - $71,377	15,897 Added 22.99%	85,039 $368,000
Q3 2023 Nov 06, 2023	SELL	$2.63 - $4.09 $405,490 - $630,592	-154,179 Reduced 69.04%	69,142 $181,000
Q2 2023 Jul 25, 2023	BUY	$2.6 - $3.58 $78,330 - $107,854	30,127 Added 15.59%	223,321 $788,000
Q1 2023 Apr 18, 2023	BUY	$2.21 - $4.82 $59,864 - $130,564	27,088 Added 16.31%	193,194 $596,000
Q3 2022 Oct 27, 2022	SELL	$2.27 - $3.84 $48,541 - $82,114	-21,384 Reduced 11.41%	166,106 $394,000
Q2 2022 Jul 27, 2022	BUY	$1.64 - $3.3 $266,550 - $536,352	162,531 Added 651.19%	187,490 $534,000
Q1 2022 Apr 25, 2022	SELL	$2.13 - $3.24 $754,403 - $1.15 Million	-354,180 Reduced 93.42%	24,959 $72,000
Q4 2021 Feb 01, 2022	BUY	$2.85 - $6.58 $1.08 Million - $2.49 Million	379,139 New	379,139 $1.15 Million
Q4 2019 Jan 17, 2020	SELL	$6.5 - $10.73 $636,311 - $1.05 Million	-97,894 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$8.75 - $12.85 $856,572 - $1.26 Million	97,894 New	97,894 $1.05 Million

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $123M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.